Stock TTI THIOGENESIS THERAPEUTICS, CORP.
Add to a list
To use this feature you must be a member
Log inSign up

News Thiogenesis Therapeutics, Corp.

Equities

TTI

CA88410L1022

Market Closed - Toronto S.E.
Other stock markets
 19:37:58 25/06/2024 BST 		5-day change 1st Jan Change
0.7 CAD -1.41% Intraday chart for Thiogenesis Therapeutics, Corp. 0.00% -6.67%
05-24 Thiogenesis Therapeutics, Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-29 Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Thiogenesis Therapeutics, Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Thiogenesis Therapeutics, Corp. Announces Acceptance of Clinical Trial Application - Part I in the EU for MELAS
CI
Thiogenesis Announces Acceptance of Clinical Trial Application - Part I in the EU for MELAS
NE
Thiogenesis Announces Closing of Final Tranche in $4.5 Million Non-Brokered Private Placement
NE
Thiogenesis Therapeutics, Corp. announced that it has received CAD 4.500875 million in funding
CI
Thiogenesis Therapeutics Completes Non-Brokered Private Placement
MT
Thiogenesis Announces Closing of Non-Brokered Private Placement of Common Shares and Insider Participation
NE
Thiogenesis Therapeutics, Corp. announces tranche update
CI
Thiogenesis CEO Invited to Lead a Round Table Discussion at Influential Mitochondria Symposium
NE
Thiogenesis Therapeutics, Corp. Announces Appointment of Vincent Stanton Jr. to the Scientific Advisory Board
CI
Thiogenesis Announces Addition of Dr. Vince Stanton Jr. to Its Scientific Advisory Board
NE
Thiogenesis Announces Non-Brokered Private Placement of Common Shares
NE
Thiogenesis Therapeutics, Corp. announced that it expects to receive CAD 4.5 million in funding
CI
Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Thiogenesis Therapeutics, Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Thiogenesis Therapeutics Completes Oversubscribed $5.3 Million Non-Brokered Private Placement
MT
Thiogenesis Therapeutics, Corp. announced that it has received CAD 5.3097 million in funding
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TTI Stock
  4. News Thiogenesis Therapeutics, Corp.